Litcius/Paper detail

Recurrence of Myopericarditis Following mRNA COVID-19 Vaccination in a Male Adolescent

Tomohiko Umei, Yoshikazu Kishino, Keiko Watanabe, Yasuyuki Shiraishi, Taku Inohara, Shinsuke Yuasa, Keiichi Fukuda

2021CJC Open15 citationsDOIOpen Access PDF

Abstract

COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease has spread worldwide, resulting in health and economic crises. Vaccination against SARS-CoV-2 infection is considered a valid prevention measure to control this pandemic. There have been reports of cases of myopericarditis following mRNA COVID-19 vaccination. We present a case of a 20-year-old man with recurrent myopericarditis following an initial episode of influenza virus-induced myopericarditis and after a second dose of the mRNA-1273 Moderna COVID-19 vaccine. Careful attention should be paid to patients with a history of myocarditis following COVID-19 vaccination.

Topics & Concepts

MyopericarditisMedicineVaccinationCoronavirus disease 2019 (COVID-19)VirologyMyocarditisDiseaseInternal medicineInfectious disease (medical specialty)Viral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 ResearchPericarditis and Cardiac Tamponade